Trial intelligence / Profile preview

Urea for Hyponatremia in Subarachnoid Hemorrhage

NCT04552873Active, not recruiting

Sponsor
CHU Grenoble Alpes
Start
Dec 2020
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of urea in hyponatremia (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Effectiveness of urea therapy in correcting persistent hyponatremia at 5 days. Started Dec 2020; status: active, not recruiting.

02

Drugs

urea
03

Conditions

hyponatremia

Beyond the preview

Go deeper on NCT04552873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04552873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call